Sprouts (SFM) Form 4: Kim Coffin Disposes 651 Shares; RSU Vesting Details
Rhea-AI Filing Summary
Kim Coffin, Senior Vice President and "Chief Forager" at Sprouts Farmers Market (SFM), reported a sale of 651 shares of common stock on 08/28/2025 at a price of $141.58 per share. After the reported transaction, the filing shows beneficial ownership of 11,235 shares, comprised of 6,729 vested shares and 4,506 restricted stock units (RSUs).
The RSUs have staggered vesting: 1,079 RSUs on Mar 14, 2026; 1,478 RSUs vesting evenly on Mar 19, 2026 and Mar 19, 2027; and 1,949 RSUs vesting evenly on Mar 12, 2026, Mar 12, 2027 and Mar 12, 2028, each contingent on continued employment. The form was signed by an attorney-in-fact on 08/29/2025.
Positive
- Complete disclosure of the sale transaction including date, price, and number of shares sold
- Detailed RSU vesting schedule is provided, clarifying when restricted units convert to shares
- Post-transaction beneficial ownership is explicitly stated (11,235 units)
Negative
- None.
Insights
TL;DR: Officer sale of 651 shares noted; remaining holdings include vested shares and time-based RSUs with multi-year vesting.
The Form 4 documents a routine sale by an executive, reducing direct holdings by 651 shares at $141.58 each. The filing also clarifies total beneficial ownership of 11,235 units, a mix of vested shares and 4,506 RSUs with detailed vesting dates through 2028. From a financial perspective, the disclosed transaction and the RSU schedule provide transparency on potential future share issuance and insider alignment with company performance, but the filing contains no information about the motivation for the sale or its proportion relative to total compensation.
TL;DR: Disclosure is complete on holdings and vesting; transaction appears properly reported under Section 16.
The Form 4 includes required details: transaction date, price, number sold, and post-transaction beneficial ownership broken down into shares and RSUs with specific vest dates. The inclusion of vesting schedules and the attorney-in-fact signature indicates procedural compliance. The filing does not state whether the sale was pre-arranged under a 10b5-1 plan and contains no indication of other governance concerns.